ClinicalTrials.govpublic full text
Neoadjuvant Treatment of Toripalimab Combined With Nab-paclitaxel and Platinum Versus Neoadjuvant Docetaxel Combined With Cisplatin and 5-fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma
esophageal squamous cell carcinoma (escc), toripalimab, dcf, neoadjuvant, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 889787
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.